What is the null hypothesis? | That adding Jedi Flow will be no more effective than thrombolysis alone in improving the mortality rate in acute MI. |

What level do we want to avoid a type I error at? (pα) | We set this to 0.05 |

What level do we want to avoid a type II error at? (pβ) | We set this to 0.8 |

What is the “clinically important difference” we want to detect? | 3% |

What is the mortality rate using thrombolysis alone? | 12% |